Suspected ventilator-associated pneumonia in cardiac patients admitted to the coronary care unit

Mayo Clinic Proceedings

Volumn 81, Issue 1, 2006, Pages 32-35

  Ensminger, S Allen ^a   Wright, R Scott ^a   Baddour, Larry M ^a   Afessa, Bekele ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROMUSCULAR BLOCKING AGENT; SEDATIVE AGENT;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BACTERIUM ISOLATION; CARDIAC PATIENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTINUOUS INFUSION; CORONARY CARE UNIT; DEMOGRAPHY; FEMALE; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PATHOGENESIS; RETROSPECTIVE STUDY; RISK FACTOR; SPHINGOMONAS PAUCIMOBILIS; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; TERTIARY HEALTH CARE; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 30144438027     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/81.1.32     Document Type: Article

References (26)

1. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in coronary care units in the United States: National Nosocomial Infections Surveillance System. Am J Cardiol. 1998;82:789-793.
2. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165:867-903.
3. Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C, Canadian Critical Trials Group. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. Am J Respir Crit Care Med. 1999;159(4, pt 1):1249-1256.
4. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical intensive care units in the United States: National Nosocomial Infections Surveillance System. Crit Care Med. 1999;27:887-892.
5. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol. 2000;21:510-515.
6. Vincent JL, Bihari DJ, Suter PM, et al, EPIC International Advisory Committee. The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study. JAMA, 1995;274:639-644.
7. Knaus WA, Draper EA, Wagner DP, Zimraerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-829.
8. Johanson WG Jr, Pierce AK, Sanford JP, Thomas GD. Nosocomial respiratory infections with gram-negative bacilli: the significance of colonization of the respiratory tract. Ann Intern Med. 1972;77:701-706.
9. Cook DJ, Walter SD, Cook RJ, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med. 1998;129:433-440.
10. Craven DE. Epidemiology of ventilator-associated pneumonia. Chest. 2000;117(4, suppl 2):186S-187S.
11. Hypothermia After Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest [published correction appears in N Engl J Med. 2002;346:1756]. N Engl J Med. 2002;346:549-556.
12. Bjork RJ, Snyder BD, Campion BC, Loewenson RB. Medical complications of cardiopulmonary arrest. Arch Intern Med. 1982;142:500-503.
13. Rello J, Valles J, Jubert P, et al. Lower respiratory tract infections following cardiac arrest and cardiopulmonary resuscitation. Clin Infect Dis. 1995;21:310-314.
14. Gajic O, Festic E, Afessa B. Infectious complications in survivors of cardiac arrest admitted to the medical intensive care unit. Resuscitation. 2004;60:65-69.
15. Grossman RF, Fein A. Evidence-based assessment of diagnostic tests for ventilator-associated pneumonia: executive summary. Chest. 2000;117(4, suppl 2):177S-181S.
16. Trouillet JL, Chastre J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med. 1998;157:531-539.
17. Cook D. Ventilator associated pneumonia: perspectives on the burden of illness. Intensive Care Med. 2000;26(suppl 1):S31-S37.
18. Warren DK, Shukla SJ, Olsen MA, et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med. 2003;31:1312-1317.
19. Bregeon F, Ciais V, Garret V, et al. Is ventilator-associated pneumonia an independent risk factor for death? Anesthesiology. 2001;94:554-560.
20. Papazian L, Bregeon F, Thirion X, et al. Effect of ventilator-associated pneumonia on mortality and morbidity. Am J Respir Crit Care Med. 1996;154:91-97.
21. Woske HJ, Roding T, Schulz I, Lode H. Ventilator-associated pneumonia in a surgical intensive care unit: epidemiology, etiology and comparison of three bronchoscopic methods for microbiological specimen sampling. Crit Care. 2001;5:167-173.
22. Crouch Brewer S, Wunderink RG, Jones CB, Leeper KV Jr. Ventilator-associated pneumonia due to Pseudomonas aeruginosa. Chest. 1996;109:1019-1029.
23. Fagon JY, Chastre J, Domart Y, Trouillet JL, Gibert C. Mortality due to ventilator-associated pneumonia or colonization with Pseudomonas or Acinetobacter species: assessment by quantitative culture of samples obtained by a protected specimen brush. Clin Infect Dis. 1996;23:538-542.
24. Kollef MH, Silver P, Murphy DM, Trovillion E. The effect of late-onset ventilator-associated pneumonia in determining patient mortality. Chest. 1995;108:1655-1662.
25. Rello J, Torres A, Ricart M, et al. Ventilator-associated pneumonia by Staphylococcus aureus: comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med. 1994;150(6, pt 1):1545-1549.
26. Dunagan DP, Burke HL, Aquino SL, Chin R Jr, Adair NE, Haponik EF. Fiberoptic bronchoscopy in coronary care unit patients: indications, safety, and clinical implications. Chest. 1998;114:1660-1667.